Cue Health, Inc. () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

1.44 k

Shareholding (Mar 2024)

FII

13.82%

Held by 26 FIIs

DII

60.73%

Held by 15 DIIs

Promoter

18.80%

How big is Cue Health, Inc.?

22-Jun-2025

As of Jun 16, Cue Health, Inc. has a market capitalization of 0.00, classifying it as a Micro Cap company, with net sales of 56.23 million and a net profit of -328.78 million over the latest four quarters. As of Dec 23, shareholder's funds are 250.25 million and total assets are 339.79 million.

Should I buy, sell or hold Cue Health, Inc.?

22-Jun-2025

Is Cue Health, Inc. overvalued or undervalued?

25-Jun-2025

As of August 10, 2022, Cue Health, Inc. is considered overvalued and risky due to significant financial challenges, including a P/E ratio of 0.00, an EV to EBITDA ratio of 0.19, a ROE of -116.50%, and a 100% stock decline over the past year, contrasting sharply with the S&P 500's 10.26% return.

Is Cue Health, Inc. technically bullish or bearish?

20-Sep-2025

As of July 1, 2024, Cue Health, Inc. shows a mildly bearish technical trend with mixed signals from indicators, having underperformed the S&P 500 significantly over the past three years.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 0 Million ()

P/E

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.18

Return on Equity

-116.50%

Price to Book

0.00

Revenue and Profits:

Net Sales:

10 Million

(Quarterly Results - Mar 2024)

Net Profit:

-50 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

0.0%

6 Months

0.0%

1 Year

0.0%

2 Years

-100.0%

3 Years

-100.0%

4 Years

-100.0%

5 Years

0.0%

Cue Health, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Is Cue Health, Inc. technically bullish or bearish?

As of 1 July 2024, the technical trend for Cue Health, Inc. has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD is also mildly bullish. However, the monthly RSI is bearish, and the daily moving averages are mildly bearish. The Bollinger Bands show a mildly bearish trend on the weekly and a sideways trend on the monthly. Dow Theory indicates no trend in both weekly and monthly time frames. In terms of performance, Cue Health has significantly underperformed the S&P 500 over the past three years, with a return of -100% compared to the S&P 500's 70.41%. Overall, the current technical stance is mildly bearish, with mixed signals from various indicators....

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-8.83%

EBIT Growth (5y)

-356.52%

EBIT to Interest (avg)

-125.32

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.18

Sales to Capital Employed (avg)

0.69

Tax Ratio

1.48%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

52.95%

ROCE (avg)

15.11%

ROE (avg)

2.18%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

EV to EBIT

0.15

EV to EBITDA

0.19

EV to Capital Employed

-0.21

EV to Sales

-0.62

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-116.50%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

Bearish

Bollinger Bands

Sideways

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2024

Shareholding Compare (%holding)

Majority shareholders

Strategic Entities

Domestic Funds

Held in 30 Schemes (6.64%)

Foreign Institutions

Held by 26 Foreign Institutions (13.82%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2024 is -46.28% vs 7.43% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2024 is 66.64% vs -215.74% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10.10",
          "val2": "18.80",
          "chgp": "-46.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-44.00",
          "val2": "-50.10",
          "chgp": "12.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.30",
          "chgp": "-66.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-6.10",
          "val2": "-83.60",
          "chgp": "92.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-49.50",
          "val2": "-148.40",
          "chgp": "66.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-4,380.10%",
          "val2": "-3,472.90%",
          "chgp": "-90.72%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is -85.34% vs -21.78% in Dec 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is -92.43% vs -686.40% in Dec 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "70.90",
          "val2": "483.50",
          "chgp": "-85.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-240.40",
          "val2": "-148.80",
          "chgp": "-61.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.20",
          "val2": "0.60",
          "chgp": "100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-77.20",
          "val2": "-2.00",
          "chgp": "-3,760.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-373.50",
          "val2": "-194.10",
          "chgp": "-92.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-4,182.80%",
          "val2": "-421.20%",
          "chgp": "-376.16%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'24 - QoQ

Mar'24

Dec'23

Change(%)

Net Sales

10.10

18.80

-46.28%

Operating Profit (PBDIT) excl Other Income

-44.00

-50.10

12.18%

Interest

0.10

0.30

-66.67%

Exceptional Items

-6.10

-83.60

92.70%

Consolidate Net Profit

-49.50

-148.40

66.64%

Operating Profit Margin (Excl OI)

-4,380.10%

-3,472.90%

-90.72%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2024 is -46.28% vs 7.43% in Dec 2023

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2024 is 66.64% vs -215.74% in Dec 2023

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'23

Dec'23

Dec'22

Change(%)

Net Sales

70.90

483.50

-85.34%

Operating Profit (PBDIT) excl Other Income

-240.40

-148.80

-61.56%

Interest

1.20

0.60

100.00%

Exceptional Items

-77.20

-2.00

-3,760.00%

Consolidate Net Profit

-373.50

-194.10

-92.43%

Operating Profit Margin (Excl OI)

-4,182.80%

-421.20%

-376.16%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2023 is -85.34% vs -21.78% in Dec 2022

Consolidated Net Profit

YoY Growth in year ended Dec 2023 is -92.43% vs -686.40% in Dec 2022

All Annual Results

Company CV

About Cue Health, Inc.

Cue Health, Inc.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

Cue Health, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Cue Health, Inc.?

Watch in Real-Time

Should I buy, sell or hold Cue Health, Inc.?

Is Cue Health, Inc. overvalued or undervalued?

Is Cue Health, Inc. technically bullish or bearish?

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Is Cue Health, Inc. technically bullish or bearish?

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Mar 2024

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Mar'24 - QoQ

Annual Results Snapshot (Consolidated) - Dec'23

About Cue Health, Inc.

Company Coordinates